行情

ABBV

ABBV

艾伯维
NYSE

实时行情|Nasdaq Last Sale

88.00
-1.26
-1.41%
盘后: 88.00 0 0.00% 18:22 01/17 EST
开盘
89.13
昨收
89.26
最高
89.27
最低
87.79
成交量
1,012.23万
成交额
--
52周最高
91.99
52周最低
62.66
市值
1,301.40亿
市盈率(TTM)
39.40
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ABBV 新闻

  • This basket of dividend growth stocks can help your portfolio stand out in 2020
  • MarketWatch.16小时前
  • Social Security’s not keeping up with inflation — here’s what that means for you
  • MarketWatch.19小时前
  • 山东未名生物医药股份有限公司关于深圳证券交易所关注函的回复公告
  • 中国证券报.1天前
  • Afraid of sky-high stock valuations? These ‘Dividend Aristocrats’ have yields over 3%
  • MarketWatch.1天前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

ABBV 简况

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
展开

Webull提供AbbVie Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。